These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 39087882)

  • 1. Comparative effectiveness of antiplatelet therapies for saphenous venous graft occlusion and cardiovascular outcomes: a network meta-analysis.
    Hasan SU; Pervez A; Afreen M; Imam B; Shah SD; Shah AA; Siddiqui SA; Zubair MM; Osho A
    Minerva Cardiol Angiol; 2024 Aug; ():. PubMed ID: 39087882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network meta-analysis of antiplatelet therapy following coronary artery bypass grafting (CABG): none versus one versus two antiplatelet agents.
    Chakos A; Jbara D; Singh K; Yan TD; Tian DH
    Ann Cardiothorac Surg; 2018 Sep; 7(5):577-585. PubMed ID: 30505741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
    Willemsen LM; Janssen PWA; Hackeng CM; Kelder JC; Tijssen JGP; van Straten AHM; Soliman-Hamad MA; Deneer VHM; Daeter EJ; Sonker U; Klein P; Ten Berg JM
    Am Heart J; 2020 Feb; 220():237-245. PubMed ID: 31884246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.
    Willemsen LM; Janssen PWA; Peper J; Soliman-Hamad MA; van Straten AHM; Klein P; Hackeng CM; Sonker U; Bekker MWA; von Birgelen C; Brouwer MA; van der Harst P; Vlot EA; Deneer VHM; Chan Pin Yin DRPP; Gimbel ME; Beukema KF; Daeter EJ; Kelder JC; Tijssen JGP; Rensing BJWM; van Es HW; Swaans MJ; Ten Berg JM
    Circulation; 2020 Nov; 142(19):1799-1807. PubMed ID: 32862716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.
    Sandner S; Redfors B; Angiolillo DJ; Audisio K; Fremes SE; Janssen PWA; Kulik A; Mehran R; Peper J; Ruel M; Saw J; Soletti GJ; Starovoytov A; Ten Berg JM; Willemsen LM; Zhao Q; Zhu Y; Gaudino M
    JAMA; 2022 Aug; 328(6):554-562. PubMed ID: 35943473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Meta-Analysis Comparing Aspirin Alone Versus Dual Antiplatelet Therapy for the Prevention of Venous Graft Failure Following Coronary Artery Bypass Surgery.
    Hesterberg K; Rawal A; Khan S; Rashid A; Jones D; Siddiqui T; Khader TA; Nayyar M; Shah R
    Cardiovasc Revasc Med; 2020 Jun; 21(6):792-796. PubMed ID: 31672535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet therapy and coronary artery bypass grafting: Protocol for a systematic review and network meta-analysis.
    Gupta S; Belley-Côté EP; Rochwerg B; Bozzo A; Panchal P; Pandey A; Mbuagbaw L; Mehta S; Schwalm JD; Whitlock RP
    Medicine (Baltimore); 2019 Aug; 98(34):e16880. PubMed ID: 31441862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: An updated meta-analysis.
    Cardoso R; Knijnik L; Whelton SP; Rivera M; Gluckman TJ; Metkus TS; Blumenthal RS; McEvoy JW
    Int J Cardiol; 2018 Oct; 269():80-88. PubMed ID: 30072154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ticagrelor for patients undergoing coronary artery bypass grafting: A meta-analysis of randomized controlled trials.
    Xiang F; Lin Y; Chen B
    Perfusion; 2023 May; 38(4):698-705. PubMed ID: 35403510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials.
    Verma S; Goodman SG; Mehta SR; Latter DA; Ruel M; Gupta M; Yanagawa B; Al-Omran M; Gupta N; Teoh H; Friedrich JO
    BMC Surg; 2015 Oct; 15():112. PubMed ID: 26467661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety outcomes of anti-platelet therapy post coronary artery bypass graft surgery: A systematic review and network meta-analysis of randomized control trials.
    Hasan SU; Pervez A; Shah AA; Shah SD; Aslam M; Arshad A; Rajput AS; Zubair MM
    Perfusion; 2024 May; 39(4):684-697. PubMed ID: 36803180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy and coronary artery bypass grafting: a systematic review and network meta-analysis.
    Gupta S; Belley-Cote EP; Panchal P; Pandey A; Basha A; Pallo L; Rochwerg B; Mehta S; Schwalm JD; Whitlock RP
    Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):354-363. PubMed ID: 32772110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ticagrelor versus aspirin and vein graft patency after coronary bypass: A randomized trial.
    Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
    J Card Surg; 2022 Mar; 37(3):563-570. PubMed ID: 34961950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
    Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
    Contemp Clin Trials; 2018 May; 68():45-51. PubMed ID: 29551675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between dual antiplatelet treatment (DAPT) score and saphenous venous grafts patency after coronary artery bypass grafting surgery.
    Bayam E; Öztürkeri B; Yıldırım E; Kalçık M; Küp A; Çakmak EÖ; Günay N; Güner A; Kalkan S; Karaduman A; Kahyaoğlu M; Zehir R
    Acta Cardiol; 2021 Sep; 76(7):785-791. PubMed ID: 33880976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin plus ticagrelor or clopidogrel on graft patency one year after coronary bypass grafting: a single-center, randomized, controlled trial.
    Tang Y; Fan X; Zhang B; Zhang J; Xue Q; Xu Z; Han L
    J Thorac Dis; 2021 Mar; 13(3):1697-1705. PubMed ID: 33841960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
    Zhao Q; Zhu Y; Xu Z; Cheng Z; Mei J; Chen X; Wang X
    JAMA; 2018 Apr; 319(16):1677-1686. PubMed ID: 29710164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis.
    Deo SV; Dunlay SM; Shah IK; Altarabsheh SE; Erwin PJ; Boilson BA; Park SJ; Joyce LD
    J Card Surg; 2013 Mar; 28(2):109-16. PubMed ID: 23488578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of clopidogrel versus aspirin as a maintenance monotherapy 1 year after coronary artery bypass grafting.
    Kim JS; Kang Y; Sohn SH; Hwang HY
    Eur J Cardiothorac Surg; 2023 Apr; 63(4):. PubMed ID: 37039835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.
    Bedenis R; Lethaby A; Maxwell H; Acosta S; Prins MH
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD000535. PubMed ID: 25695213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.